Drug intelligence / Profile preview

autologous peripheral blood mesenchymal stem cells

Development stage
Unknown
Modality
Stem Cell Therapies → Cell Therapies
Administration
Intravenous, Intraarticular, Intrathecal, Intracoronary, Intramyocardial, Intratendinous
01

Overview

Autologous peripheral blood mesenchymal stem cells are multipotent stromal cells isolated from a patient's own (autologous) peripheral blood. These cells can differentiate into various cell types including osteoblasts, chondrocytes, myocytes, and adipocytes. They are used in regenerative medicine due to their ability to home to sites of injury or inflammation and secrete bioactive factors that promote tissue repair and modulate immune responses. The use of the patient’s own (autologous) MSCs reduces the risk of immune rejection and eliminates donor compatibility concerns. Clinical applications under investigation include orthopedic injuries (such as cartilage or tendon repair), autoimmune diseases, cardiovascular conditions, neurological disorders, graft-versus-host disease prevention/treatment after transplantation, and other degenerative diseases[2][3][5][6]. The procedure typically involves mobilizing stem cells into the bloodstream with growth factors (e.g., G-CSF), collecting them via apheresis from peripheral blood, processing/concentrating them in a laboratory setting if needed, then re-infusing or injecting them at the site of injury[2][4].

Other names
autologous MSCsautologous peripheral blood MSCsautologous mesenchymal stromal cells

Beyond the preview

Go deeper on autologous peripheral blood mesenchymal stem cells.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on autologous peripheral blood mesenchymal stem cells.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call